Simms Michael J 4
4 · Alexza Pharmaceuticals Inc. · Filed May 14, 2012
Insider Transaction Report
Form 4
Simms Michael J
SVP, Operations & Manufact
Transactions
- Award
Common Stock
2012-05-10+100,000→ 225,825 total
Footnotes (2)
- [F1]Represents shares issued as restricted stock units (an 'RSU') under the Issuer's 2005 Equity Incentive Plan (the 'Plan'). The RSUs will vest in full on August 24, 2012, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time.
- [F2]Includes, as previously reported: (i) 46,222 RSUs granted under Plan that will vest in full on the earlier of June 5, 2012 or a Change in Control (as defined in the Plan), provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time, and (ii) 45,582 RSUs granted under the Plan pursuant to the terms of the Issuer's 2009-2010 Performance Based Incentive Program (the 'Performance Program') that will vest on the date the U.S. Food and Drug Administration approves the Issuer's New Drug Application for its ADASUVE (Staccato loxapine) product candidate, if ever, provided that at the relevant vesting date the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.